Dalbavancin Therapy for Infective Endocarditis
NCT07699211
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
184
Enrollment
OTHER
Sponsor class
Conditions
Endocarditis Infective
Endocarditis, Bacterial
Interventions
DRUG:
Dalbavancin administration
DRUG:
Standard of Care (Investigator Choice)
Sponsor
Stefan Hagel